4
Changes in Ownership
Aquestive Therapeutics, Inc. Filed Acc 0001214659-23-006558
Options or other derivatives
- Chief Innovation/Tech Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Schobel Alexander Mark · Chief Innovation/Tech Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-05-05 | Grant or award : show line 1 in the form Performance Stock Units | +50,000 | 50,000 | D |
Loading xslF345X04/marketforms-61240.xml…